注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Lisata Therapeutics Inc(原名:Caladrius Biosciences, Inc.),是一家临床阶段的生物制药公司。该公司从事治疗晚期实体瘤和其他主要疾病的疗法的发现、开发和商业化。该公司主要专注于在一系列肿瘤适应症中推进其CendR平台技术产品候选者。该公司的主要研究产品候选者LSTA1旨在通过激活允许抗癌药物穿透实体瘤的摄取途径来改变肿瘤微环境。LSTA1以肿瘤特异性方式激活主动转运系统,导致系统性共同给药的抗癌药物在肿瘤中渗透和积累,而正常组织不受影响。此外,该公司还拥有基于自体CD34+细胞治疗技术平台的临床开发项目。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Gregory Bailey Brown | 67 | 2016 | Independent Chairman of the Board |
Robert S. Negrin | - | - | Immune Modulation Program Advisor |
Timothy D. Henry | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Joseph C. Wu | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
David A. Horwitz | - | - | Immune Modulation Program Advisor |
Mark Peakman | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Thomas J. Povsic | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Andreas Zeiher | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Todd Brusko | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Robert Korngold | - | - | Immune Modulation Program Advisor |
Noel L. Warner | - | - | Immune Modulation Program Advisor |
David Pearce | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Arshed A. Quyyumi | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Cathleen Noel Bairey Merz | 66 | 2019 | Member of Cardiovascular Disease Scientific Advisory Board |
David Peritt | 57 | - | Immune Modulation Program Advisor |
Gerald T. Nepom | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Richard A. Schatz | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Kevan Herold | - | - | Member of Type 1 Diabetes Scientific Advisory Board |
Cynthia L. Flowers | 62 | 2018 | Independent Director |
Christopher J. White | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Laurence A. Turka | 64 | - | Member of Type 1 Diabetes Scientific Advisory Board |
Michael Gibson | - | 2019 | Member of Cardiovascular Disease Scientific Advisory Board |
William Fearon | - | - | Member of Cardiovascular Disease Scientific Advisory Board |
Steven M. Klosk | 66 | 2014 | Independent Director |
Mohammad Azab | 67 | 2022 | Independent Director |
Heidi Henson | 57 | 2022 | Independent Director |
David J. Mazzo | 66 | 2015 | President, CEO & Director |
Erkki Ruoslahti | 82 | 2022 | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核